性欲低下の治療法
1Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montréal, QC H4B 1R6, Canada.
Cell
|October 27, 2015
まとめ
フリバンセリンは脳内のセロトニン受容体を標的にしてドーパミンとノラドレナリンレベルを調節する. このメカニズムは 女性の性欲を高める鍵です
科学分野:
- 神経薬理学
- 神経科学
- 内分泌学
背景:
- セロトニンは 気分と性機能の調節に 複雑な役割を果たします
- モノアミンの神経伝達物質の調節不良は,低活動性性欲障害 (HSDD) に関わっている.
研究 の 目的:
- HSDDの治療におけるフリバンセリンの神経薬理学的メカニズムを解明する.
- フリバンセリンが性欲に 重要な神経伝達物質のシステムに どのように影響するか理解するためです
主な方法:
- セロトニン5HT1A自己受容体と5HT2A受容体に対するフリバンセリンの作用が研究されました.
- ドーパミンとノラドレナリンの流通に対する薬物の影響を評価した.
主要な成果:
- フリバンセリンは,5-HT1A自己受容体と結合することで,セロトニンの放出を抑制する.
- また,5-HT2A受容体におけるセロトニンのポストシナプス作用を阻害する.
- これはドーパミンとノラドレナリンの循環を抑制する.
結論:
- ドーパミンとノラドレナリンを間接的に増加させるセロトニンを調節します.
- この神経化学的調節は 性欲に対する治療効果に 極めて重要です
さらに関連する動画
関連する概念動画
Treatment Strategies for Psychological Disorders
920
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
920
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
728
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
728
Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Psychosexual Stages of Personality: Genital
2.1K
The genital stage is the final phase of Sigmund Freud's theory of psychosexual development, beginning at puberty, around age 12. During this stage, sexual energy shifts from self-focused interests to external individuals, marking the development of mature adult sexuality. Freud saw this phase as a time of sexual reawakening, with desires directed toward others outside the family. A healthy transition into this stage, according to Freud, signifies the emergence of two key aspects of adult...
2.1K
Male Sexual Response: Erection & Ejaculation
27.0K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
27.0K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
602
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
602


